Rocephin and Methotrexate sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rocephin (ceftriaxone sodium) and Methotrexate sodium (methotrexate sodium). Common drug interactions include abdominal adhesions among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Rocephin and Methotrexate sodium. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Rocephin?

Rocephin has active ingredients of ceftriaxone sodium. It is often used in infection. eHealthMe is studying from 15,665 Rocephin users. Check the latest studies of Rocephin.

What is Methotrexate sodium?

Methotrexate sodium has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. eHealthMe is studying from 97,679 Methotrexate sodium users. Check the latest studies of Methotrexate sodium.



On Jul, 11, 2026

22 people who take Rocephin and Methotrexate sodium together, and have interactions are studied.

Rocephin and Methotrexate sodium drug interactions.

What are the common drug interactions of Rocephin and Methotrexate Sodium, by gender? *:

female:

  1. Abdominal adhesions (inflammation of abdomen)
  2. Abdominal pain
  3. Abdominal pain lower
  4. Arthralgia (joint pain)
  5. Asthenia (weakness)
  6. Blood creatine phosphokinase increased
  7. Blood lactate dehydrogenase increased
  8. Body temperature increased
  9. Chills (felling of cold)
  10. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

male:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Parainfluenzae virus infection
  3. Bronchostenosis (narrowing of a bronchial tube by scarring or other stricture)
  4. Fall
  5. Hypokalaemia (low potassium)
  6. Hypovolaemia (a decreased volume of circulating blood in the body)
  7. Influenza like illness
  8. Nasopharyngitis (inflammation of the nasopharynx)
  9. Oral candidiasis (fungal infection of mouth)
  10. Respiratory failure (inadequate gas exchange by the respiratory system)

What are the common drug interactions of Rocephin and Methotrexate Sodium, by age (0-1 to 60+)? *:

0-1:

  1. Bronchostenosis (narrowing of a bronchial tube by scarring or other stricture)
  2. Hypokalaemia (low potassium)

2-9:

  1. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  2. Pulmonary oedema (fluid accumulation in the lungs)
  3. Respiratory distress (difficulty in breathing)

10-19:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Parainfluenzae virus infection
  3. Venoocclusive liver disease (small veins in the liver are obstructed)
  4. Thrombocytopenia (decrease of platelets in blood)

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal adhesions (inflammation of abdomen)
  2. Abdominal pain
  3. Abdominal pain lower
  4. Arthralgia (joint pain)
  5. Asthenia (weakness)
  6. Blood creatine phosphokinase increased
  7. Blood lactate dehydrogenase increased
  8. Body temperature increased
  9. Chills (felling of cold)
  10. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

50-59:

  1. Drug hypersensitivity

60+:

  1. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  2. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  3. Renal failure acute (rapid kidney dysfunction)
  4. Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)
  5. Acute generalised exanthematous pustulosis (acute febrile drug eruption)
  6. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  7. Acute respiratory distress syndrome
  8. Alanine aminotransferase increased
  9. Aplasia (defective development or congenital absence of an organ or tissue)
  10. Blood alkaline phosphatase increased

What are the existing conditions these people have? *

  1. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 6 people, 27.27%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 13.64%
  3. Peripheral T-Cell Lymphoma Unspecified (peripheral t-cell cancer unspecified): 3 people, 13.64%
  4. Fever: 3 people, 13.64%
  5. Encephalitis Viral (inflammation of the brain due to viral infection): 3 people, 13.64%
  6. Bacterial Infection: 3 people, 13.64%

* Approximation only. Some reports may have incomplete information.

Do you take Rocephin and Methotrexate sodium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Rocephin and Methotrexate sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rocephin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Methotrexate sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rocephin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methotrexate sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ceftriaxone sodium and methotrexate sodium (the active ingredients of Rocephin and Methotrexate sodium, respectively), and Rocephin and Methotrexate sodium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: